RT Journal Article T1 Meropenem heteroresistance in clinical isolates of OXA-48-producing Klebsiella pneumoniae. A1 Lopez-Camacho, Elena A1 Paño-Pardo, Jose Ramon A1 Sotillo, Alma A1 Elias-Lopez, Cristina A1 Martinez-Martinez, Luis A1 Gomez-Gil, Rosa A1 Mingorance, Jesus K1 Carbapenem K1 Heteroresistance K1 Klebsiella pneumoniae K1 OXA-48 K1 Porin AB OXA-48-producing Klebsiellapneumoniae isolates often show growth of colonies within inhibition zones in carbapenem diffusion assays. The nature of these colonies was investigated in a series of clinical isolates of OXA-48-producing K. pneumoniae obtained in the context of a hospital outbreak, and they were found to be persistent colonies that reproduced again the same phenotype when they were collected and tested in diffusion assays again. The frequency of mutations conferring resistance to meropenem (8 μg/mL) was determined for the same isolates. The average mutation frequency was 5.47·10-6 (range: 2.59·10-8-5.87·10-5), and the analysis of several resistant mutants showed that all of them had mutations in the ompK36 porin gene. Heteroresistance was investigated using population analysis profiling. The profiles were compatible with mutation frequency assays, and all the colonies analyzed were resistant mutants. In OXA-48-producing K. pneumoniae, the growth of persisters seems to be specific of diffusion assays. PB Elsevier YR 2018 FD 2018-09-14 LK http://hdl.handle.net/10668/13042 UL http://hdl.handle.net/10668/13042 LA en NO López-Camacho E, Paño-Pardo JR, Sotillo A, Elías-López C, Martínez-Martínez L, Gómez-Gil R, et al. Meropenem heteroresistance in clinical isolates of OXA-48-producing Klebsiella pneumoniae. Diagn Microbiol Infect Dis. 2019 Feb;93(2):162-166 DS RISalud RD Apr 9, 2025